• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并感染 COVID-19 的患者。

co-infection in patients with COVID-19.

机构信息

Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, 8-2 Trubetskaya str., Moscow, 119991, Russian Federation.

The Interregional Public Organization 'Scientific Community for the Promotion of the Clinical Study of the Human Microbiome', Pogodinskaya Street, 1, Building 1, Moscow, 119435, Russian Federation.

出版信息

Future Microbiol. 2022 Jun;17:653-663. doi: 10.2217/fmb-2021-0145. Epub 2022 Apr 20.

DOI:10.2217/fmb-2021-0145
PMID:35440149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9020461/
Abstract

To assess the impact of infection on the course of COVID-19. The authors included 809 patients with COVID-19 in this retrospective study: 55 had infection, 23 had -negative antibiotic-associated diarrhea and 731 had no diarrhea. in feces was determined by immunochromatographic test for its toxins. infection was associated with increased risk of death (hazard ratio = 2.6; p = 0.021), especially after 20 days of disease (hazard ratio = 6.5; p < 0.001). infection-associated diarrhea was longer and more severe than -negative antibiotic-associated diarrhea. Unlike patients with -negative antibiotic-associated diarrhea, patients with infection were admitted to the intensive care unit and needed mechanical ventilation more often than those without diarrhea. infection worsens the course and prognosis of COVID-19.

摘要

为评估 感染对 COVID-19 病程的影响。作者在这项回顾性研究中纳入了 809 例 COVID-19 患者:55 例有 感染,23 例有 -阴性抗生素相关性腹泻,731 例无腹泻。粪便中的 通过免疫层析试验检测其毒素来确定。感染与死亡风险增加相关(危险比=2.6;p=0.021),尤其是在疾病发生 20 天后(危险比=6.5;p<0.001)。与 -阴性抗生素相关性腹泻相比, 感染相关腹泻持续时间更长,更严重。与 -阴性抗生素相关性腹泻患者不同, 感染患者更常被收入重症监护病房并需要机械通气。 感染可使 COVID-19 的病程和预后恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be1/9020461/b318d3e6d8ea/figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be1/9020461/0b1af957583b/figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be1/9020461/b318d3e6d8ea/figure2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be1/9020461/0b1af957583b/figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5be1/9020461/b318d3e6d8ea/figure2.jpg

相似文献

1
co-infection in patients with COVID-19.合并感染 COVID-19 的患者。
Future Microbiol. 2022 Jun;17:653-663. doi: 10.2217/fmb-2021-0145. Epub 2022 Apr 20.
2
Risk factors for complicated course and recurrence of Clostridioides Difficile infections during COVID-19 pandemic.COVID-19 大流行期间艰难梭菌感染复杂病程和复发的危险因素。
Przegl Epidemiol. 2022;77(1):23-33. doi: 10.32394/pe.77.02.
3
Prevalence of Clostridioides difficile and Other Gastrointestinal Pathogens in Patients with COVID-19.新冠病毒感染者中艰难梭菌和其他胃肠道病原体的流行情况。
Dig Dis Sci. 2021 Dec;66(12):4398-4405. doi: 10.1007/s10620-020-06760-y. Epub 2021 Jan 22.
4
Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.COVID-19 住院患者中艰难梭菌感染的临床特征、预测因素和结局——来自塞尔维亚伏伊伏丁那大学临床中心 COVID 医院的单中心经验。
Medicina (Kaunas). 2022 Sep 12;58(9):1262. doi: 10.3390/medicina58091262.
5
The interplay of SARS-CoV-2 and infection.SARS-CoV-2 与 感染的相互作用。
Future Microbiol. 2021 Apr;16:439-443. doi: 10.2217/fmb-2020-0275. Epub 2021 Apr 13.
6
A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.艰难梭菌感染与抗生素相关性腹泻综述
Gastroenterol Clin North Am. 2021 Jun;50(2):323-340. doi: 10.1016/j.gtc.2021.02.010.
7
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月,美国密歇根州底特律市,COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
8
Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.巴西南部艰难梭菌感染和复发的流行病学多中心研究。
Anaerobe. 2020 Aug;64:102238. doi: 10.1016/j.anaerobe.2020.102238. Epub 2020 Jul 24.
9
Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.抗生素对艰难梭菌感染和复发小鼠模型中艰难梭菌易感性和感染株的影响。
Anaerobe. 2020 Apr;62:102149. doi: 10.1016/j.anaerobe.2020.102149. Epub 2020 Jan 12.
10
Health care associated Clostridioides difficile infection and colonization in patients admitted at tertiary care hospital Pakistan.巴基斯坦三级医院收治患者中与医疗保健相关的艰难梭菌感染和定植情况
J Pak Med Assoc. 2022 Apr;72(4):610-615. doi: 10.47391/JPMA.0461.

引用本文的文献

1
Evaluation of Inflammatory Markers and Clinical Outcomes in COVID-19 Patients with Concurrent Infection: A Comparative Cohort Analysis.新冠病毒肺炎合并感染患者炎症标志物与临床结局的评估:一项比较队列分析
Biomedicines. 2025 Jan 6;13(1):111. doi: 10.3390/biomedicines13010111.
2
Hyperbaric oxygen augments susceptibility to infection by impairing gut microbiota ability to stimulate the HIF-1α-IL-22 axis in ILC3.高压氧通过损害肠道微生物群落刺激 ILC3 中 HIF-1α-IL-22 轴的能力,增强了对感染的易感性。
Gut Microbes. 2024 Jan-Dec;16(1):2297872. doi: 10.1080/19490976.2023.2297872. Epub 2024 Jan 2.
3
Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with : Single-Center Study from NE Romania during the COVID-19 Pandemic.

本文引用的文献

1
Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection.新型冠状病毒感染中早期病毒相关性腹泻与晚期抗生素相关性腹泻的比较。
Medicine (Baltimore). 2021 Oct 15;100(41):e27528. doi: 10.1097/MD.0000000000027528.
2
Prevalence and impact of infection among hospitalized patients with coranavirus disease 2019.2019年冠状病毒病住院患者感染的患病率及影响
JGH Open. 2021 Mar 30;5(5):622-625. doi: 10.1002/jgh3.12497. eCollection 2021 May.
3
A clinical variant of Coronavirus disease 2019 with diarrhea as the initial symptom compared with other variants.
新冠疫情期间罗马尼亚东北部单中心研究:新型冠状病毒肺炎合并感染患者的症状、治疗及转归
Antibiotics (Basel). 2023 Jun 22;12(7):1091. doi: 10.3390/antibiotics12071091.
4
Fulminant Clostridioides difficile Colitis With SARS-CoV-2 Infection.伴有新型冠状病毒感染的暴发性艰难梭菌结肠炎
Cureus. 2023 May 1;15(5):e38401. doi: 10.7759/cureus.38401. eCollection 2023 May.
5
The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study.多重耐药菌导致 COVID-19 患者发生医院获得性感染:一项回顾性多中心研究。
J Hosp Infect. 2023 Jul;137:1-7. doi: 10.1016/j.jhin.2023.04.013. Epub 2023 Apr 28.
6
Antibiotic Usage in the COVID-19 Intensive Care Unit of an Infectious Diseases Hospital from Nord-Eastern Romania.罗马尼亚东北部传染病医院 COVID-19 重症监护病房的抗生素使用情况。
Medicina (Kaunas). 2023 Mar 24;59(4):645. doi: 10.3390/medicina59040645.
7
High Prevalence of Ribotype 176 in the University Hospital in Kosice.科希策大学医院中核糖体分型176的高流行率。
Pathogens. 2023 Mar 8;12(3):430. doi: 10.3390/pathogens12030430.
8
Diarrhea and Coronavirus Disease 2019 Infection.腹泻与 2019 冠状病毒病感染。
Gastroenterol Clin North Am. 2023 Mar;52(1):59-75. doi: 10.1016/j.gtc.2022.11.001. Epub 2022 Nov 14.
9
The Impact of Clostridioides Difficile Infection in Hospitalized Patients: What Changed during the Pandemic?艰难梭菌感染对住院患者的影响:疫情期间有哪些变化?
Diagnostics (Basel). 2022 Dec 16;12(12):3196. doi: 10.3390/diagnostics12123196.
10
Clinical Presentations, Predictive Factors, and Outcomes of Clostridioides difficile Infection among COVID-19 Hospitalized Patients—A Single Center Experience from the COVID Hospital of the University Clinical Center of Vojvodina, Serbia.COVID-19 住院患者中艰难梭菌感染的临床特征、预测因素和结局——来自塞尔维亚伏伊伏丁那大学临床中心 COVID 医院的单中心经验。
Medicina (Kaunas). 2022 Sep 12;58(9):1262. doi: 10.3390/medicina58091262.
Minerva Gastroenterol (Torino). 2022 Dec;68(4):487-489. doi: 10.23736/S2724-5985.21.02827-0. Epub 2021 Apr 15.
4
The interplay of SARS-CoV-2 and infection.SARS-CoV-2 与 感染的相互作用。
Future Microbiol. 2021 Apr;16:439-443. doi: 10.2217/fmb-2020-0275. Epub 2021 Apr 13.
5
Diarrhoea in adults with coronavirus disease-beyond incidence and mortality: a systematic review and meta-analysis.成人冠状病毒病腹泻:发病率和死亡率之外:系统评价和荟萃分析。
Infect Dis (Lond). 2021 May;53(5):348-360. doi: 10.1080/23744235.2021.1885733. Epub 2021 Feb 15.
6
Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?艰难梭菌感染与 2019 年冠状病毒病(COVID-19):被低估的问题?
Pol Arch Intern Med. 2021 Feb 26;131(2):121-127. doi: 10.20452/pamw.15715. Epub 2020 Dec 14.
7
The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid).2019冠状病毒病大流行期间艰难梭菌感染的负担:意大利医院的一项回顾性病例对照研究(CloVid)
J Clin Med. 2020 Nov 27;9(12):3855. doi: 10.3390/jcm9123855.
8
Prevalence and Mortality of COVID-19 Patients With Gastrointestinal Symptoms: A Systematic Review and Meta-analysis.COVID-19 患者伴胃肠道症状的患病率和死亡率:一项系统评价和荟萃分析。
Mayo Clin Proc. 2020 Aug;95(8):1632-1648. doi: 10.1016/j.mayocp.2020.06.003. Epub 2020 Jun 10.
9
Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.2020 年 3 月-4 月,美国密歇根州底特律市,COVID-19 患者中的艰难梭菌。
Emerg Infect Dis. 2020 Sep;26(9):2272-4. doi: 10.3201/eid2609.202126. Epub 2020 May 22.
10
A Review of Coronavirus Disease-2019 (COVID-19).新型冠状病毒肺炎(COVID-19)概述。
Indian J Pediatr. 2020 Apr;87(4):281-286. doi: 10.1007/s12098-020-03263-6. Epub 2020 Mar 13.